Pan-Asia Catalysts/Events, Quiddity Advisors

David Blennerhassett

HK Type 4 license through Ballingal Investment Advisors Ltd. 

I'm a highly experienced sell-side analyst with in excess of 22 years of covering Asia Pacific equities, the past 19 years immersed in event strategies encompassing M&A risk arbitrage, directional long/short, stub trades and restructuring.  

My background also includes accountancy (liquidation/bankruptcy/receivership) earlier in my career and as a chief financial officer of a global commodity company based in the US and Mexico.

Pan-Asia Catalysts/Events

Kangji Medical (9997 HK): Q&A With The FA

Kangji Medical (9997 HK): 10th Nov Shareholder Vote on Founders/TPG/QIA's Offer

Kangji Medical (9997 HK): A Closer Look At The Shareholder Register

Kangji Medical (9997 HK): Speedy Turnaround On Pre-Cons

Quiddity Advisors

Event-Driven

Hangzhou Kangji Medical Instrument Co., Ltd. / Event-Driven

Hangzhou Kangji Medical Instrument Co., Ltd. (9997 HK)

Hangzhou Kangji Medical Instrument Co., Ltd.

<ul>
<li>
<strong>6.95%.</strong> That's the key number at yesterday's Scheme Meeting for <strong><a href="https://www.smartkarma.com/entities/hangzhou-kangji-medical-instrument-co-ltd" target="_blank" data-smartkarma-citation="entities:28938:1" rel="noopener">Hangzhou Kangji Medical Instrument Co., Ltd. (9997 HK)</a>.</strong>
</li>
<li>That's still below the 10% blocking stake. But closer than the bankers and the market was anticipating. </li>
<li>Arguably, the terms were therefore bang on. Last day of trading is today, with payment on the 16th December.</li>
</ul>



6.95%. That's the key number at yesterday's Scheme Meeting for Hangzhou Kangji Medical Instrument Co., Ltd. (9997 HK).

That's still below the 10% blocking stake. But closer than the bankers and the market was anticipating. 
Arguably, the terms were therefore bang on. Last day of trading is today, with payment on the 16th December.


Kangji Medical (9997 HK): A Close Run Thing